U S DIAGNOSTIC INC
8-K, 1999-04-07
MEDICAL LABORATORIES
Previous: MONACO COACH CORP /DE/, PRE 14A, 1999-04-07
Next: GREENPOINT FINANCIAL CORP, 8-K, 1999-04-07



<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT


                       PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported):  April 6, 1999

                               US DIAGNOSTIC INC.
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


                                    DELAWARE
- --------------------------------------------------------------------------------
                 (State or other jurisdiction of incorporation)

             1-13392                                     11-3164389 
    ------------------------                          -------------------
    (Commission File Number)                            (IRS Employer 
                                                      Identification No.)


777 SOUTH FLAGLER DRIVE, SUITE 1201, EAST TOWER, 
          WEST PALM BEACH, FLORIDA                                    33401
- --------------------------------------------------------------------------------
(Address of principal executive offices)                            (Zip Code)

Registrant's telephone no. including area code:        (561) 832-0006


<PAGE>   2


ITEM 5. OTHER EVENTS

On April 6, 1999, the Company announced that it has set its 1999 Annual Meeting
of Shareholders for June 10, 1999 and the record date with respect thereto for
April 22, 1999. In accordance with the Company's Bylaws, (i) shareholder
proposals submitted for inclusion in the Company's proxy statement and form of
proxy must be received by the Company no later than April 17, 1999; and (ii)
shareholder proposals not submitted for inclusion in the Company's proxy
statement and form of proxy shall be considered untimely (and the persons named
in the proxies solicited by the Company's Board of Directors may exercise
discretionary voting power with respect thereto) if not received by April 17,
1999.



                                       2

<PAGE>   3

                                   SIGNATURES

         Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.



                                     US DIAGNOSTIC INC.

Dated:  April 7, 1999


                                     By:  /s/ Joseph A. Paul  
                                          -----------------------------
                                          Joseph A. Paul
                                          President and Chief Executive Officer







                                        3


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission